Evidence map›Paper›PMID 40356919›Full record

ReviewFrontiers in immunology2025

Deep learning for malignant lymph node segmentation and detection: a review.

Wenxia Wu, Adrien Laville, Eric Deutsch, Roger Sun

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wenxia WuUnité Mixte de Recherche (UMR) 1030, Gustave Roussy, Department of Radiation Oncology, Université Paris-Saclay, Villejuif, France.
Adrien LavilleUnité Mixte de Recherche (UMR) 1030, Gustave Roussy, Department of Radiation Oncology, Université Paris-Saclay, Villejuif, France.
Eric DeutschUnité Mixte de Recherche (UMR) 1030, Gustave Roussy, Department of Radiation Oncology, Université Paris-Saclay, Villejuif, France.
Roger SunUnité Mixte de Recherche (UMR) 1030, Gustave Roussy, Department of Radiation Oncology, Université Paris-Saclay, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy remains a cornerstone in the treatment of cancer, with the delineation of Organs at Risk (OARs), tumors, and malignant lymph nodes playing a critical role in the planning process. However, the manual segmentation of these anatomical structures is both time-consuming and costly, with inter-observer and intra-observer variability often leading to delineation errors. In recent years, deep learning-based automatic segmentation has gained increasing attention, leading to a proliferation of scholarly works on OAR and tumor segmentation algorithms utilizing deep learning techniques. Nevertheless, similar comprehensive reviews focusing solely on malignant lymph nodes are scarce. This paper provides an in-depth review of the advancements in deep learning for malignant lymph node segmentation and detection. After a brief overview of deep learning methodologies, the review examines specific models and their outcomes for malignant lymph node segmentation and detection across five clinical sites: head and neck, upper extremity, chest, abdomen, and pelvis. The discussion section extensively covers the current challenges and future trends in this field, analyzing how they might impact clinical applications. This review aims to bridge the gap in literature by providing a focused overview on deep learning applications in the context of malignant lymph node challenges, offering insights into their potential to enhance the precision and efficiency of cancer treatment planning.

Indexed as

Deep LearningLymphatic MetastasisLymph NodesNeoplasmsHumansdeep learningdelineationdetectionlymph nodesegmentation

Identifiers

PMID40356919
PMCPMC12066500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.